Adult Sinusitis in 2023: Is It Time for Guideline Updates?

PROGRAM DESCRIPTION: The American Academy of Otolaryngology – Head and Neck Surgery Foundation clinical practice guideline on adult sinusitis provides important evidence-based recommendations for clinical practitioners to effectively diagnose and treat patients with acute and chronic rhinosinusitis. The guideline was first published in 2007 and was last updated in 2015. Since 2015, however, significant advances in the understanding of the pathophysiology and clinical manifestations of specifically chronic rhinosinusitis (CRS) have resulted in modifications in the diagnostic workup, treatment strategies, and health counseling of patients. The recognition of phenotypes and endotypes in CRS, increased emphasis placed on the relationship between CRS and asthma, and introduction of biological therapies as treatment options for CRS are examples of the dynamic and evolving nature of CRS management. This panel discussion will provide a case-based approach to highlight differences between the 2015 guideline and current evidence-based strategies in the workup and treatment of CRS patients. Such a discussion will offer suggestions for quality improvements in the next iteration of the 2015 guideline.

OUTCOME OBJECTIVE 1: To describe new understandings of the disease pathophysiology, diagnostic workup, and treatment strategies for adult CRS since the most recent update to the AAO-HNS guideline on adult sinusitis in 2015

OUTCOME OBJECTIVE 2: To review the importance of endotyping as a method to classify different variants of CRS and to guide treatment options

OUTCOME OBJECTIVE 3: To highlight the role of biological therapies in the management of CRS and their potential position in the CRS treatment algorithm

BACKGROUND STATEMENT: With discussion on new therapeutic options for CRS, this panel will specifically address an educational gap in rhinology through its focus on the use of biological therapies in the management of sinonasal diseases.